ATE477798T1 - Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung - Google Patents

Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung

Info

Publication number: ATE477798T1
Authority: AT; Austria
Prior art keywords: agomelatin; medications; treatment; production; anxiety disorder
Prior art date: 2006-04-07

Application number

AT07290420T

Other languages

English (en)

Inventor

Bruno Delalleau

Agnes Fabiano

Mark Millan

Elisabeth Mocaer

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-07

Filing date

2007-04-06

Publication date

2010-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE477798(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-04-06 Application filed by Servier Lab filed Critical Servier Lab

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE477798T1 publication Critical patent/ATE477798T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT07290420T 2006-04-07 2007-04-06 Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung ATE477798T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0603083A FR2899472B1 (fr)	2006-04-07	2006-04-07	Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (1)

Publication Number	Publication Date
ATE477798T1 true ATE477798T1 (de)	2010-09-15

Family

ID=37308935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07290420T ATE477798T1 (de)	2006-04-07	2007-04-06	Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung

Country Status (44)

Country	Link
US (1)	US7960438B2 (de)
EP (1)	EP1842535B1 (de)
JP (1)	JP4880031B2 (de)
KR (1)	KR20070100657A (de)
CN (1)	CN101049290B (de)
AP (1)	AP2488A (de)
AR (1)	AR060349A1 (de)
AT (1)	ATE477798T1 (de)
AU (1)	AU2007201527B2 (de)
BR (1)	BRPI0701601A (de)
CA (1)	CA2584060C (de)
CO (1)	CO5840252A1 (de)
CR (1)	CR9019A (de)
CY (1)	CY1111287T1 (de)
DE (1)	DE602007008494D1 (de)
DK (1)	DK1842535T3 (de)
EA (1)	EA012608B1 (de)
ES (1)	ES2351062T3 (de)
FR (1)	FR2899472B1 (de)
GE (1)	GEP20094743B (de)
GT (1)	GT200700032A (de)
HK (1)	HK1108367A1 (de)
HR (1)	HRP20100577T1 (de)
IL (1)	IL182407A (de)
JO (1)	JO3440B1 (de)
MA (1)	MA28987B1 (de)
ME (1)	ME01865B (de)
MX (1)	MX2007004100A (de)
MY (1)	MY143269A (de)
NI (1)	NI200700084A (de)
NO (1)	NO20071774L (de)
NZ (1)	NZ554347A (de)
PE (1)	PE20080174A1 (de)
PL (1)	PL1842535T3 (de)
PT (1)	PT1842535E (de)
RS (1)	RS51485B (de)
SA (1)	SA07280161B1 (de)
SG (1)	SG136881A1 (de)
SI (1)	SI1842535T1 (de)
TN (1)	TNSN07118A1 (de)
TW (1)	TWI374736B (de)
UY (1)	UY30262A1 (de)
WO (1)	WO2007116136A1 (de)
ZA (1)	ZA200702865B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101481321B (zh) *	2009-02-27	2012-04-18	上海医药工业研究院	阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) *	2009-03-10	2014-04-02	上海医药工业研究院	阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) *	2010-02-11	2012-03-02	Servier Lab	Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190595A (zh) *	2010-03-17	2011-09-21	上海医药工业研究院	阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) *	2010-03-17	2011-09-21	上海医药工业研究院	阿戈美拉汀氯化氢水合物及其制备方法
PH12012000132A1 (en) *	2011-06-09	2014-10-20	Servier Lab	New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) *	2011-08-10	2013-07-26	Servier Lab	Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810656B1 (de)	2013-06-06	2017-08-02	Zentiva, a.s.	Agomelatin-Formulierungen, enthaltend Agomelatin in Co-Kristallform
EP2810647A1 (de)	2013-06-06	2014-12-10	Zentiva, a.s.	Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure
IT201900002913A1 (it)	2019-03-01	2020-09-01	Nicola Pescosolido	Composto utile per il trattamento del glaucoma
CN110867197A (zh) *	2019-10-23	2020-03-06	吴杰	语音交互过程中实时打断语音机器人的方法及设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2658818B1 (fr) *	1990-02-27	1993-12-31	Adir Cie	Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5737438A (en) *	1994-03-07	1998-04-07	International Business Machine Corp.	Image processing
DE19532842C1 (de) *	1995-09-05	1996-12-19	Ibm	Bildaufnahmesystem
AR047553A1 (es) *	2003-07-04	2006-01-25	Lundbeck & Co As H	La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
CA2551637A1 (en) *	2003-12-24	2005-07-14	Sepracor Inc.	Melatonin combination therapy for improving sleep quality
FR2866335B1 (fr) *	2004-02-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'agomelatine
US20060199805A1 (en) *	2005-03-04	2006-09-07	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
US7635721B2 (en) *	2005-08-03	2009-12-22	Les Laboratoires Servier	Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) *	2005-08-03	2008-04-15	Les Laboratories Servier	Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) *	2005-11-18	2007-10-01	Astrazeneca Ab	Pharmaceutical compositions

2006
- 2006-04-07 FR FR0603083A patent/FR2899472B1/fr active Active
2007
- 2007-03-26 PE PE2007000340A patent/PE20080174A1/es not_active Application Discontinuation
- 2007-03-26 AP AP2007003953A patent/AP2488A/xx active
- 2007-03-28 GT GT200700032A patent/GT200700032A/es unknown
- 2007-03-28 CR CR9019A patent/CR9019A/es not_active Application Discontinuation
- 2007-03-28 TN TNP2007000118A patent/TNSN07118A1/fr unknown
- 2007-03-29 NI NI200700084A patent/NI200700084A/es unknown
- 2007-04-03 MA MA29798A patent/MA28987B1/fr unknown
- 2007-04-03 NO NO20071774A patent/NO20071774L/no not_active Application Discontinuation
- 2007-04-03 CO CO07033655A patent/CO5840252A1/es not_active Application Discontinuation
- 2007-04-04 MX MX2007004100A patent/MX2007004100A/es active IP Right Grant
- 2007-04-04 US US11/732,762 patent/US7960438B2/en active Active
- 2007-04-04 TW TW096112141A patent/TWI374736B/zh active
- 2007-04-04 AR ARP070101420A patent/AR060349A1/es unknown
- 2007-04-05 MY MYPI20070536A patent/MY143269A/en unknown
- 2007-04-05 GE GEAP20079966A patent/GEP20094743B/en unknown
- 2007-04-05 SG SG200702552-1A patent/SG136881A1/en unknown
- 2007-04-05 AU AU2007201527A patent/AU2007201527B2/en active Active
- 2007-04-05 ZA ZA200702865A patent/ZA200702865B/xx unknown
- 2007-04-05 NZ NZ554347A patent/NZ554347A/en unknown
- 2007-04-05 JO JOP/2007/0119A patent/JO3440B1/ar active
- 2007-04-05 BR BRPI0701601-8A patent/BRPI0701601A/pt not_active Application Discontinuation
- 2007-04-06 EA EA200700574A patent/EA012608B1/ru unknown
- 2007-04-06 PL PL07290420T patent/PL1842535T3/pl unknown
- 2007-04-06 SI SI200730345T patent/SI1842535T1/sl unknown
- 2007-04-06 DE DE602007008494T patent/DE602007008494D1/de active Active
- 2007-04-06 JP JP2009503617A patent/JP4880031B2/ja active Active
- 2007-04-06 KR KR1020070034003A patent/KR20070100657A/ko active Search and Examination
- 2007-04-06 CN CN2007100910721A patent/CN101049290B/zh active Active
- 2007-04-06 EP EP07290420A patent/EP1842535B1/de not_active Revoked
- 2007-04-06 RS RSP-2010/0497A patent/RS51485B/en unknown
- 2007-04-06 ME MEP-2010-497A patent/ME01865B/me unknown
- 2007-04-06 PT PT07290420T patent/PT1842535E/pt unknown
- 2007-04-06 WO PCT/FR2007/000586 patent/WO2007116136A1/fr active Application Filing
- 2007-04-06 AT AT07290420T patent/ATE477798T1/de active
- 2007-04-06 DK DK07290420.4T patent/DK1842535T3/da active
- 2007-04-06 ES ES07290420T patent/ES2351062T3/es active Active
- 2007-04-07 SA SA07280161A patent/SA07280161B1/ar unknown
- 2007-04-09 UY UY30262A patent/UY30262A1/es not_active Application Discontinuation
- 2007-04-10 CA CA2584060A patent/CA2584060C/fr active Active
- 2007-04-10 IL IL182407A patent/IL182407A/en active IP Right Grant
- 2007-12-13 HK HK07113624.0A patent/HK1108367A1/xx unknown
2010
- 2010-10-07 CY CY20101100897T patent/CY1111287T1/el unknown
- 2010-10-21 HR HR20100577T patent/HRP20100577T1/hr unknown

Also Published As

Publication number	Publication date
AU2007201527B2 (en)	2012-08-09
BRPI0701601A (pt)	2007-12-11
CO5840252A1 (es)	2007-12-31
KR20070100657A (ko)	2007-10-11
TWI374736B (en)	2012-10-21
MA28987B1 (fr)	2007-11-01
NI200700084A (es)	2008-04-24
DK1842535T3 (da)	2010-11-15
DE602007008494D1 (de)	2010-09-30
CN101049290B (zh)	2012-10-31
SI1842535T1 (sl)	2010-10-29
SG136881A1 (en)	2007-11-29
EP1842535A1 (de)	2007-10-10
JP4880031B2 (ja)	2012-02-22
MY143269A (en)	2011-04-15
EA200700574A2 (ru)	2007-10-26
PT1842535E (pt)	2010-09-28
ZA200702865B (en)	2008-07-30
AP2007003953A0 (en)	2007-04-30
HRP20100577T1 (hr)	2010-11-30
CA2584060A1 (fr)	2007-10-07
AU2007201527A1 (en)	2007-10-25
PL1842535T3 (pl)	2011-01-31
FR2899472B1 (fr)	2008-09-12
AR060349A1 (es)	2008-06-11
JP2009532446A (ja)	2009-09-10
ES2351062T3 (es)	2011-01-31
TNSN07118A1 (fr)	2008-06-02
US20070238792A1 (en)	2007-10-11
CA2584060C (fr)	2011-04-26
CN101049290A (zh)	2007-10-10
HK1108367A1 (en)	2008-05-09
WO2007116136A1 (fr)	2007-10-18
TW200808295A (en)	2008-02-16
JO3440B1 (ar)	2019-10-20
EA012608B1 (ru)	2009-10-30
AP2488A (en)	2012-10-03
ME01865B (me)	2011-04-30
GEP20094743B (en)	2009-07-27
GT200700032A (es)	2007-10-31
SA07280161B1 (ar)	2010-10-23
NZ554347A (en)	2008-08-29
EA200700574A3 (ru)	2007-12-28
EP1842535B1 (de)	2010-08-18
IL182407A (en)	2016-02-29
FR2899472A1 (fr)	2007-10-12
RS51485B (en)	2011-04-30
CR9019A (es)	2008-10-28
US7960438B2 (en)	2011-06-14
CY1111287T1 (el)	2015-08-05
NO20071774L (no)	2007-10-08
MX2007004100A (es)	2009-02-16
UY30262A1 (es)	2007-05-31
PE20080174A1 (es)	2008-03-29
IL182407A0 (en)	2008-01-20

Publication	Publication Date	Title
ATE477798T1 (de)	2010-09-15	Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung
EP2118940A4 (de)	2011-03-09	Vorrichtung zur kontinuierlichen herstellung von supraleitenden bändern
DE602007013512D1 (de)	2011-05-12	Verfahren zur kontinuierlichen Herstellung von Bauteilen
EP1981526A4 (de)	2011-03-02	Adiponectin zur behandlung verschiedener erkrankungen
ATE434620T1 (de)	2009-07-15	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP2050319A4 (de)	2010-12-08	Verfahren zur herstellung von leitern und halbleitern
EP2158254A4 (de)	2011-10-05	Poly(organophosphazen)-hydrogele zur arzneistoffzufuhr, herstellungsverfahren dafür und verwendung davon
ATE512661T1 (de)	2011-07-15	Verwendung eines betablockers zur herstellung eines arzneimittels zur behandlung von hämangiomen
EP2248171A4 (de)	2012-09-12	Halbleiterkonstruktionen und verfahren zur herstellung von halbleiterkonstruktionen
EP1758597A4 (de)	2008-02-27	Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz
EP2285825A4 (de)	2012-11-28	Verfahren zur herstellung nichtimmunogener hydrophoper proteinnanopartikel und ihre verwendung
DE112007001307A5 (de)	2009-04-30	Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
DE602007007146D1 (de)	2010-07-29	Verfahren zur Herstellung von Müsliriegeln mit verbesserter Konsistenz
ATE550329T1 (de)	2012-04-15	Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP4091585C0 (de)	2024-12-18	Vorrichtung zur behandlung von refluxösophagitis
EP2366794A4 (de)	2015-01-21	Verfahren zur herstellung von poly-3-hydroxyalkanoat und poly-3-hydroxyalkanoatagglomerat
DE502006007528D1 (de)	2010-09-09	Verfahren zur kontinuierlichen Herstellung von Kohlenstofffasern
EP2056848A4 (de)	2010-11-17	Verwendung von extrakten zur behandlung viraler erkrankungen
EP3821910C0 (de)	2024-12-25	Oligosaccharid und verfahren zur herstellung davon
DE112008000701A5 (de)	2010-08-12	Zusammensetzung zur Herstellung von Speisern
EP2787799A4 (de)	2015-07-29	Platine mit eingebetteter komponente und verfahren zu ihrer herstellung sowie gehäuse mit platine mit eingebetteter komponente
EP2257516A4 (de)	2012-12-12	Verfahren zur herstellung von cyclododecatrien und verfahren zur herstellung von laurolacton
ATE483460T1 (de)	2010-10-15	Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602008002968D1 (de)	2010-11-25	Gerät zur Herstellung von RFID-Etiketten
EP2389171A4 (de)	2012-10-10	Verwendung von pterosinverbindungen zur behandlung von diabetes und adipositas

Legal Events

Date	Code	Title	Description
2011-09-15	UEP	Publication of translation of european patent specification	Ref document number: 1842535 Country of ref document: EP

Date

Code

Title

Description

2011-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1842535

Country of ref document: EP